30.08.2014 - 04.09.2014, Paris (F)

FEBS-EMBO 2014 Conference

The FEBS–EMBO 2014 Conference will be a unique international event that brings together many leading researchers to discuss the latest scientific findings in the life sciences. Scientists from across the world will be able to attend a jointly organized conference that offers unparalleled scope for the entire range of the molecular life sciences. The conference will also celebrate the 50th anniversaries of FEBS and EMBO and the 100th anniversary of the French Society for Biochemistry and Molecular Biology.



30.11.2015 - 02.12.2015

6th World Congress on Biotechnology

Hyderabad (IN)

The Congress is the global forum basing on the Theme: Biotechnology: Meeting the Needs of a Changing World. It aims to promote the international and national exchange of ideas, promote collaborative research network among academia and industry. Besides this dissemination of knowledge this world congress brings an opportunity for professionals to build up a scientific and professional network as well. Young researchers, postdoctoral researchers, graduate students and other professionals are warmly welcome to the Workshop entitled “NIH Research Resources in Biotechnology”.
Contact: Rajesh K. Guru, OMICS Group

BioFIT 2015


01.12.2015 - 02.12.2015

BioFIT 2015

Strasbourg (F)

leading partnering event in Europe for open innovation, technology transfer and collaborative research in the field of Life Sciences
Contact: Marion Sigier, eurosante/Nutrition Sante Longevte

5th Munich Biomarker Conference


01.12.2015 - 02.12.2015

5th Munich Biomarker Conference

Munich (GER)

The Munich Biomarker Conference brings together international experts from biotech and pharma industry with scientists and physicians. The programme covers all stages of biomarker development, from basic research to personalized treatment of patients. A focus lies on the translation of academic research findings into industry-driven drug development. A second core topic is the realization of individualized treatment in the standard of care. How can clinical processes, data management and reimbursement be adjusted to unleash the potential of personalized medicine? Strategies to overcome current limitations and possible solutions are discussed.
Contact: Dr. Almut Windhager, BioM Biotech Cluster Development GmbH

09.12.2015 - 10.12.2015

The 2015 Biopolymer Summit

London (UK)

The Summit will bring together key industry experts to discuss the latest strategies and methods to overcome current challenges, and maximise the opportunities. The conference will address how the industry will evolve, current trends, how to respond to the changes of the market and the growing demand from end users. Over the two days, the event will bring insights into end users expectations and environmental approaches, amongst others. Attendees will also be able to interact and discuss regional markets, while developing future business opportunity in biopolymers.
Contact: Mohammad Ahsan, ACI

11.02.2016 - 12.02.2016

Plant Genes and „Omics“: Technology Development

Vienna (A)

The international conference will discuss wide range of modern technologies to discover plant gene, its function and various “Omics” tools and technologies and it will provide leading academy and industry scientists a platform to communicate recent advances and an opportunity to establish multilateral collaborations.
Contact: VISCEA


9th Berlin Conference on IP in Life Sciences - Digital Health Solutions


The Berlin Conference on IP in Life Sciences has become a must-attend for life sciences decision makers, IP and legal experts, business developers and investors. The upcoming event will explore the potential of digital health technologies for the Life Sciences sector and discuss relevant interfaces of the pharma, biotechnology, medical care and IT sector.
Against the background of an ongoing digital change progress, the conference is designed to provide deep insights into the e-Health market conditions across Europe and beyond. It will highlight the most important next generation IT and personalised medicine solutions which provide pharma, diagnostics and medical care companies with new tools to delevelop treatments and diagnostics, to deliver a better experience to patients, to improve clinical outcomes and to reduce total costs.
Further topics covered during the conference include the impact of IT on Life Science R&D as well as on translational medicine, challenges of big data in the clinical environment as well as the role life science companies are able to play within the new set-up of doctor-to-doctor and doctor-to-patient communication. Furthermore, legal issues regarding the use and the patenting of new digital health products will be discussed.
Contact: Uta Holmer, BIOCOM AG
Phone: +49-30-2649-21-53, Fax: +49-30-2649-21-66

18.02.2016 - 19.02.2016

6th Crossroads in Biology


CIB Symposium is organized entirely by graduate students and aims at bringing together
leading scientists from diverse areas of biological research in an interactive environment.
They have already received confirmation of attendance from 10 speakers from
Europe, USA and Australia including Prof. Stefan Hell (Nobel Prize in Chemistry, 2014).
Contact: Universität Köln

06.03.2016 - 09.03.2016

ECO-BIO 2016

Rotterdam (NL)

Challenges in building a Sustainable Bioeconomy – This conference will be a first of its kind and will highlight the emergence of the research and innovation field, where we are today and what needs to be done to develop an economically feasible, safe, sustainable, and ecologically friendly biobased future. The conference will be a platform to further the discussions on this highly societal relevant topic.
Contact: BE-Basic Foundation/Elsevier

© 2007-2015 BIOCOM


Current issue

All issues


All videos

Product of the week


Stock list

All quotes


  • DIAMYD MEDICAL -B- (S)10.00 SEK14.29%
  • SERODUS (N)2.67 NOK9.43%


  • EVOCUTIS (UK)0.09 GBP-10.00%
  • VERONA PHARMA (UK)3.05 GBP-6.15%
  • SAREUM HOLDINGS (UK)0.19 GBP-5.00%


  • PLETHORA (UK)5.62 GBP80.1%
  • PROTHENA PLC (IE)73.19 USD40.9%
  • CELLECTIS (F)30.70 EUR32.3%


  • EPIGENOMICS (D)1.87 EUR-58.5%
  • EVOCUTIS (UK)0.09 GBP-40.0%


  • KARO BIO (S)38.10 SEK5342.9%
  • CHRONTECH PHARMA (S)0.34 SEK1600.0%
  • GALAPAGOS (B)45.70 EUR254.3%


  • BIOTEST (D)15.34 EUR-81.0%
  • EVOCUTIS (UK)0.09 GBP-78.6%

No liability assumed, Date: 26.11.2015


All Events


Strasbourg (F)

BioFIT 2015